Showing results (461-470 of 519) with videos related to

Sort By:
Pageof 52
Breast Cancer Research and Treatment|May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancerErik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trialJohn M S Bartlett, Cassandra L Brookes, Tammy Robson, et al.
Bone Marrow Transplantation|March 11, 2026
An extraction pipeline for analysis of hematopoietic stem cell transplantation dataErik G J von Asmuth, Constantijn J M Halkes, Jurjen Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2024
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trialWouter H Zwart, Sofieke J D Temmink, Geke A P Hospers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial CancerNanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysisWillemien van de Water, Duveken B Y Fontein, Johanna G H van Nes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysisDuveken B Y Fontein, Caroline Seynaeve, Peyman Hadji, et al.
Pageof 52